Loading...

GALERA THERAPEUTICS INC Capital Structure Changes 8-K Filing

GLR

GALERA THERAPEUTICS INC

()

2026 8-K

Stock Increase Approved

Stockholder Meeting Results

Merger Announcement

Stock Conversion Completed

Annual Meeting Notice

Preferred Stock Amendment

Executive Bonus Agreement

Asset Sale Agreement

Asset Sale Agreement

Royalty Agreement Update

Agreement Amendment

Acquisition Completed

Director Elections

External Links:

On May 11, 2026, Galera Therapeutics, Inc. increased its authorized shares from 200 million to 400 million and provided stockholders a right to act by written consent, approved during the Annual Meeting on May 8, 2026.

AI Assistant

GALERA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.